|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investment securities: | ||||||||||||||||||||
| Debt securities, at fair value (amortized cost of $94,063 and $96,669, respectively) | ||||||||||||||||||||
| Equity securities, at fair value (cost of $1,832 and $1,836, respectively) | ||||||||||||||||||||
| Equity securities, at fair value (cost of $883 and $1,276, respectively) | ||||||||||||||||||||
| Short-term investments, at fair value | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Premiums and agents' balances receivable, net | ||||||||||||||||||||
| Receivable from Affiliate | ||||||||||||||||||||
| Reinsurance recoverables on unpaid losses | ||||||||||||||||||||
| Reinsurance recoverables on paid losses | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Receivable from contingent considerations | ||||||||||||||||||||
| Receivable from contingent consideration | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets from discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Unpaid losses and loss adjustment expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Reinsurance premiums payable | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Mandatorily redeemable preferred stock | ||||||||||||||||||||
| Funds held under reinsurance agreements | ||||||||||||||||||||
| Premiums payable to other insureds | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Liabilities from discontinued operations | ||||||||||||||||||||
| Payables for investments purchased | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Series A Preferred Stock, no par value (10,000,000 shares authorized; 0 and 1,000 issued and outstanding, respectively) | ||||||||||||||||||||
| Common stock, no par value (100,000,000 shares authorized; 3,746,092 and 1,746,125 issued and outstanding, respectively) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity |
Loading...
